Conclusions It is known that MR provides more information about anatomical changes associated with brain diseases and to enable the anatomical allocations of subregions than CT, though this was not observed in the present study. Although the subregional BR of simultaneous PET/MR was comparable to that of PET/CT in Parkinson's disease, our isocontouring method could make bias. A future automated method using standard template study or manual segmentation of putamen/ caudate based on MR or CT is needed.
Introduction
Parkinsonian disorder is among the most common neurodegenerative diseases in elderly individuals with Alzheimer's disease [1, 2] . Its main clinical symptoms are akinesia, rigidity, resting tremor, and poor balance (postural instability) [3] . The cause of parkinsonian disorder is not known, but idiopathic Parkinson's disease is the most common cause. Furthermore, the clinical symptoms of Parkinson's disease are associated with lesions in the substantia nigra. Atypical parkinsonian disorders, such as, multiple system atrophy, corticobasal degeneration, progressive supranuclear palsy, and dementia with Lewy bodies, also account for a large percentage of parkinsonian disorder cases [4] .
Many studies have been performed to improve the accuracy of differential diagnosis in patients with parkinsonian This manuscript has not been published before or is not under consideration for publication anywhere else and has been approved by all co-authors.
disorder, these include studies on 2-deoxy-2-[ 18 F] fluoro-Dglucose positron emission tomography/computed tomography ( 1 8 F-FDG PET/CT), dual-radionuclide dopamine transporter(DAT) and brain perfusion single photon emission computed tomography (SPECT), and diffusion-weighted magnetic resonance imaging (MRI) [5] [6] [7] . Recently F-18 fluorinated-N-3-fluoropropyl-2-bcarboxymethoxy-3-b-(4-iodophenyl) nortropane ( 18 F-FP-CIT) PET/CT became available for use in parkinsonian disorder for DAT imaging. 18 F-FP-CIT PET/CT makes it possible to evaluate regional DAT densities in the brain and to differentiate parkinsonian disorders into subtypes [8, 9] .
However, CT imaging of the brain is limited by lack of soft tissue differentiation, and recently a whole-body fully integrated PET/MR scanner was introduced [10] [11] [12] , and for brain lesions, it has been suggested the higher soft tissue contrast of MRI could provide more information about brain anatomical changes [13, 14] .
Given this background, the purpose of the present study was to compare the performances of conventional 
Materials and Methods

Subjects
Fifteen patients (five men, ten women; mean age 65.1 ± 10.4 years; age range, 48-79 years) were recruited consecutively (Table 1 ). All study subjects were clinically suspected of having Parkinson's disease due to akinesia, rigidity, and resting tremor or postural instability by an experienced neurologist, and all provided informed consent. The study was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki, and was approved by the Institutional Review Board of Yeungnam University Hospital (IRB no. YUH-13-0430-O57).
Data Acquisition
18
F-FP-CIT PET was performed using a PET/CT (Discovery VCT, GE Medical Systems, Milwaukee, WI, USA) and a PET/MR unit (Biograph mMR, Siemens Medical Solution, Hoffman Estates, Knoxville, TN, USA). All patients underwent emission scan after injecting 185 MBq (5 mCi) of 18 F-FP-CIT -antiparkinsonian drugs were stopped 12 h before scans were performed.
PET/CT image acquisition was started 90 min after the intravenous injection of 18 F-FP-CIT. Brain CT was performed in helical mode at auto mAs (50-200 mAs) and 120 kVp. 18 F-FP-CIT PET images were acquired in the 3-dimensional (3D) mode for 10 min. The protocols for reconstruction were iterative reconstruction with 20 subsets/2 iterations. The matrix size for attenuation correction was 128 × 128, and a 2.57 mm gaussian filter and a fully 3D iterative algorithm (VUE Point HD) were applied.
Subsequently PET/MR with T1-weighted magnetization prepared rapid gradient echo (MPRAGE) and diffusion sequences including a ultrashort echo-time (UTE) sequence was performed (mean time interval between PET/CT and PET/MR 37.3 ± 20.1 min; range 19-87 min). The PET/MR imaging acquisition protocols were as follows; iterative reconstruction with 21 subsets/5 iterations, matrix size 344 × 344, and a 4 mm gaussian post reconstruction filter was used. All patients underwent MR imaging with an UTE sequence, conducted with a repetition time of 11.94 ms, echo time 1 of 0.07 ms, echo time 2 of 2.46 ms, field of view 300 × 300 mm, matrix size 192 × 192, and flip angle 10°. PET data were acquired over a single bed position of 30 cm covering the head and neck for 20 min. Syngo MR VB20P software was used for all patients. PET/MR systems used segmentation-based attenuation correction (AC) based on an attenuation map derived from MR images.
Data Analysis
PET images were interpreted by visual inspection and quantitative analysis. DAT densities in bilateral striatal subregions were performed visually. Quantitative analyses were based on bilateral striatal volumes of interest (VOIs) using average standardized uptake values (SUVmeans) and standardized uptake values (SUV) is commonly used as a relative measure of FDG uptake. SUV is a mathematically derived ratio of tissue radioactivity concentration at a point in time and the injected dose of radioactivity per kilogram of the patient's body weight.
Four VOIs of bilateral striatal subregions (bilateral caudate nucleus and putamen) and one cerebellar VOI (from just below the inferior margin of the occipital lobe to the lower margin of the cerebellum) were drawn manually on respective PET scans by an experienced nuclear medicine physician specializing in nuclear neurology ( Fig. 1) . Three-dimensional iso-contouring VOIs of 40 % max-threshold were created to calculate mean SUVs as in previous oncologic studies [15, 16] . Activity concentrations were calculated for VOIs. Binding ratio (BR) was defined as follows: (SUVmean of striatal subregional VOI -SUVmean of cerebellar VOI)/SUVmean of cerebellar VOI [17] . BRs of bilateral striatal subregions were calculated (BR right caudate, BR left caudate , BR right putamen and BR left putamen ). The analysis procedure was conducted on a dedicated workstation using commercial software (PET/CT -Advantage Workstation version 4.6, GE; and PET/MR -Syngo MMWP and Syngo TrueD, Siemens Medical Solutions, respectively).
Statistical Analysis
The analysis was performed using SPSS for windows (SPSS, Chicago, IL, USA). All continuous values are presented as means and standard deviations. The nonparametric Wilcoxon [18, 19] . Bland-Altman plots were also drawn to compare the two modalities, as previously described [20, 21] . Probability values of less than 0.05 were considered statistically significant.
Results
Visual Assessment
Visual inspection of 18 F-FP-CIT PET scans showed 14 of the 15 subjects exhibited decreased DAT density on bilateral striata. The other subject showed decreased DAT density on unilateral striatum. Both PET/CT and PET/MR showed reduced DAT densities in bilateral or unilateral striata (particularly in the posterior putamen,Brabbit hip^sign on maximumintensity-projection images). Visual evaluations made by 18 F-FP-CIT brain PET/MR and simultaneous 18 F-FP-CIT PET/CT agreed. All subjects were visually diagnosed with Parkinson's disease by common consent (Fig. 2) . No patient showed acute infarction and one had an old lacunar infarction in both basal ganglia.
Quantitative Assessment
SUVmeans of the four bilateral subregions and cerebellum were measured in PET/CT and PET/MR images. Overall, average regional PET/CT SUVs were significantly higher than PET/MR SUVs (average SUVmeans right caudate 5.41 ± 1.54, left caudate 5.61 ± 1.34, right putamen 5.03 ± 1.58, left putamen 4.93 ± 1.31, and cerebellum 1.03 ± 0.17 for PET/CT; and right caudate 3.87 ± 1.17, left caudate 4.00 ± 1.02, right putamen 3.59 ± 1.22, left putamen 3.49 ± 1.02, and cerebellum 0.73 ± 0.11 for PET/MR, p < 0.001, respectively) ( Table 2) . Overall the SUVmean of the bilateral striatal subregion showed excellent interequipment agreement in ICCs between PET/CT and PET/MR (Fig. 3) .
BRs obtained by PET/CT and PET/MR were not significantly different (Table 2) SUVmeans average standardized uptake values BR binding ratio interequipment agreement in ICCs. To estimate the reliability between both PET/CT and PET/MR, we also designed BlandAltman plots. BRs in Bland-Altman plots showed that most dots were contained within the CIs. BR of caudate nucleus shows more variable than those of putamen and BR on PET/ MR was lower than BR on PET/CT (right caudate 0.073 ± 1.58, left caudate 0.044 ± 1.65, right putamen 0.054 ± 1.11, left putamen 0.066 ± 1.06, respectively) (Fig. 4) .
Discussion
Parkinson's disease and atypical parkinsonism (such as multiple system atrophy and progressive supranuclear palsy) exhibit significantly decreased striatal DAT density and each disorder shows different preferential subregional DAT binding values when examined by FP-CIT SPECT and PET [22] [23] [24] . The recent introduction of 18 F-FP-CIT PET/CT enables presynaptic DAT imaging in parkinsonian disorder, and it is also possible to evaluate regional DAT densities in the brain [8, 9] . However, CT imaging of the brain is limited by a lack of soft tissue differentiation. In brain lesions, the higher soft tissue contrast of MRI could provide more information about brain anatomical changes [12] [13] [14] , and recently a fully integrated PET/MR scanner was introduced [10] [11] [12] .
Although brain PET/MR has several advantages in terms of brain tissue segmentation and anatomic information over PET/CT, controversy continues as whether PET/CT and PET/ MR data are replaceable [25] . The present study indicates . Previous oncologic PET studies have also indicated that there is no significant difference between the PET data obtained by PET/MR and PET/CT with respect to image quality [26, 27] . Quantification of 18 F-FP-CIT has been considered an important issue in clinical brain PET studies [28, 29] . It is essential to achieve accurate quantification for 18 F-FP-CIT PET for clinical applications given the development of quantitative imaging based biomarkers. In particular, DAT imaging have been regarded as a biomarker of nigrostriatal dopaminergic pathway dysfunction. In this context, spatially and temporally coregistered PET/MR may have advantages in terms of accurately defining structures for quantification [17] .
In previous studies, binding potentials calculated from striatal regional ratios were found to be useful when 18 F-FP-CIT reaches equilibrium binding in the brain [30, 31] . For quantitative analysis, we calculated DAT BRs from PET/MR and PET/CT based on manually drawn VOIsand as a preliminary report, simple and fast striatum segmentation method was employed. This simple method could provide acceptable quantification for DAT binding of F-FP-CIT [32] . The BRs of bilateral striata showed interequipment reliability in the present study ( [33] . This finding agrees with a previous report issued by Choi et al. [17] , who compared BRs using PET template and performed statistical probabilistic anatomic mapping derived from 18 F-FP-CIT brain PET data using the PET/MR and PET/CT approaches. They found that BRs of caudate and putamen showed excellent interequipment agreements when non-AC data from PET/ MR and PET/CT were used. Nevertheless, DAT BR in the caudate nucleus was significantly underestimated by PET/ MR, compared with PET/CT because of spatial bias of attenuation map. Our results showed excellent interequipment agreements when AC data from PET/MR and PET/CT were used. It is not clear about this difference but in the present study, we used the isocontouring method which may not fully include the caudate nucleus and the bias of our quantification method could make this difference.
Our study has several limitations. The first limitation is that only a small number of patients were included. Second, we used PET/MR (Biograph mMR, Siemens Medical Solution) and PET/CT (Discovery VCT, GE Medical Systems) scanners from different manufacturers; Delso G et al. showed that even when PET/CT and PET/MR scanners from the same vendor were used, PET detectors were significantly different [34] . Third, we examined only two regions (caudate nucleus and putamen), and thus, further studies on more segmented subregions (anterior caudate, posterior caudate, anterior putamen, posterior putamen, and ventral putamen) are needed as previous studies [35] . Fourth, the study is limited by the use of serial PET protocols and by PET/MR acquisition after PET/ CT. Moreover, scan acquisition times and times between PET/ CT and PET/MR scans were not standardized (mean time between PET/CT and PET/MR 37.3 ± 20.1 min; interval range 19-87 min). Accordingly, a study is required that takes into account possible dynamic changes in the binding potential of 18 F-FP-CIT for PET/CT and PET/MR. Furthermore, reconstruction protocols differed for PET/CT and PET/MR, and this could have affected the quantification of PET data. But smoothing with a Gaussian filter could help comparability between PET images with different matrix size [36, 37] . Fifth, the isocontour approach have a lot of limitations, such as underestimation of SUV [38] and the tracer uptake heterogeneity can influence the delineation results [15] . To obtain more accurate quantification, automated method using standard template study or manual segmentation of putamen/ caudate based on MR or CT is needed.
Conclusion
In spite of a later imaging time-point, PET image qualities of PET/CT and PET/MR were found to be comparable in terms of discriminating parkinsonian disorders. Although the subregional BR of simultaneous PET/MR was comparable to that of PET/CT in this study, isocontouring method using maxthreshold could make serious bias. An additional, largerscale prospective study and automated method using standard template study or manual segmentation of putamen/caudate based on MR or CT is needed that includes image quality analysis.
